| Financial Year |
March 31 2023 |
| Monetary Funds |
270,161,193.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,099,486.41 |
| Accounts Receivable |
423,818,113.06 |
| Advances to Suppliers |
8,455,188.41 |
| Other Receivables |
81,861,382.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
718,259,195.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,075,069.71 |
| Total Current Assets |
1,642,306,556.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
22,932,882.33 |
| Investment Properties |
3,684,895.86 |
| Fixed Assetes |
1,038,901,144.64 |
| Under-construction Projects |
75,784,695.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
135,109,912.50 |
| R&D expenses |
-- |
| Goodwill |
156,277,075.43 |
| Long-Term Deferred and Prepaid Expenses |
11,787,612.43 |
| Deferred Income Tax Assets |
26,295,310.29 |
| Other Non-Current Assets |
80,315,686.82 |
| Sub-Total of Non-Current Assets |
1,589,170,348.22 |
| Total Assets |
3,231,476,904.37 |
| Short-Term Loans |
364,956,744.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,527,000.00 |
| Accounts Payable |
278,361,840.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,681,359.02 |
| Taxes Payable |
16,569,185.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,274,067.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
79,284,651.02 |
| Other Current Liabilities |
20,831,525.15 |
| Sub-Total of Current Liabilities |
902,452,599.54 |
| Long-term Loans |
57,258,174.73 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
62,082,713.42 |
| Other Non-Current Liabilities |
9,945,495.39 |
| Sub-Total of Non-Current Liabilities |
208,911,908.54 |
| Total Liabilities |
1,111,364,508.08 |
| Paid-In Capital(Or Share Stock) |
657,189,708.00 |
| Capital Surplus |
556,498,642.19 |
| Surplus Reserve |
93,878,642.45 |
| LESS:Treasury Stock |
50,989,661.24 |
| Undistributed Profits |
407,174,889.57 |
| Minority Stockholder's Interest |
465,566,452.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,654,545,944.13 |
| Owner's Equity（Stockholder's Equity） |
2,120,112,396.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,231,476,904.37 |
